Incidence and susceptibility or pathogenic bacteria vary between intensivecare units within a single hospital: Implications for empiric antibiotic strategies
N. Namias et al., Incidence and susceptibility or pathogenic bacteria vary between intensivecare units within a single hospital: Implications for empiric antibiotic strategies, J TRAUMA, 49(4), 2000, pp. 638-645
Background: The purpose of this study was to determine whether the incidenc
e of recovery and patterns of antibiotic susceptibility of pathogenic bacte
ria vary between intensive care units (ICUs) in a single teaching hospital.
Methods: Culture and susceptibility results were collected prospectively fo
r a 3-month period (April through June 1999) in each of the surgical, traum
a, and medical ICUs, The number of unique isolates and susceptibility patte
rns were determined. Susceptibility of isolates among ICUs was compared wit
h chi(2).
Results: statistically significant differences between ICUs in susceptibili
ty to various antibiotics were found for Staphylococcus aureus, Enterococcu
s sp, Acinetobacter sp, Enterobacter sp, Klebsiella sp, and Pseudomonas sp,
Notably, vancomycin-resistant Enterococcus was not seen in the medical ICU
, whereas it was seen in both the surgical and trauma ICUs, Klebsiella spp
resistant to ceftazidime were seen only in the trauma ICU, The aminoglycosi
des and quinolones had attenuated activity against Pseudomonas sp in the su
rgical ICU, whereas they remained highly effective in the trauma ICU. Cefaz
olin had no activity against the Enterobacter sp in either of the surgical
ICUs, but was highly effective in the medical ICU.
Conclusion: Although the microbiologic results of this study should not be
extrapolated to other institutions, the principle is of value. There is var
iability between ICUs in a single large teaching hospital in susceptibility
of bacterial pathogens to various antibiotics. This may have implications
in the design of empiric antibiotic strategies and the planning of the hosp
ital formulary. Hospital wide or composite ICU antibiograms are inadequate
for planning empiric therapy in the ICU.